PetCaseFinder

Peer-reviewed veterinary case report

Can basal cortisol replace ACTH test for monitoring dog Cushing's?

By Theodora Tsouloufi & Ioannis Oikonomidis·Published in Veterinary Evidence·2021·University of Edinburgh, Royal (Dick) School of Veterinary Studies, GB·View original on DOAJ

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Trilostane monitoring in canine hyperadrenocorticism: can basal cortisol measurement replace the ACTH stimulation test?

Species:
dog

Plain-English summary

A 10-year-old female Beagle with hyperadrenocorticism (Cushing's disease) was being treated with trilostane and had her cortisol levels monitored to check how well the treatment was working. Researchers found that measuring cortisol levels a few hours after the trilostane dose could help rule out adrenal oversuppression, but it wasn't reliable enough to confirm if the treatment was effective. This means that while checking cortisol can be useful, it shouldn't be the only method used to monitor the dog's response to treatment. The vet will need to consider the dog's overall health and symptoms when deciding on the best care plan.

People also search for: dog Cushing's disease treatment · trilostane monitoring in dogs · Beagle hyperadrenocorticism symptoms

Abstract

PICO question In dogs with hyperadrenocorticism that are being treated with trilostane, does the measurement of basal cortisol levels have comparable diagnostic performance to the adrenocorticotropic hormone (ACTH) stimulation test?   Clinical bottom line Category of research question Diagnosis (effectiveness of treatment monitoring) The number and type of study designs reviewed Four cross-sectional diagnostic accuracy studies were critically reviewed Strength of evidence Weak to moderate (level 2) Outcomes reported There is evidence of moderate strength suggesting that basal cortisol measured at 4–6 hours (and possibly 2–3 hours) post-trilostane can be a good test to exclude adrenal oversuppression, while its use is not suggested for diagnostic confirmation of oversuppression. There is evidence of weak strength that basal cortisol might be helpful for identifying dogs with inadequate adrenal suppression, but cannot be used to rule it out Conclusion Although the evaluation of the available evidence is difficult due to its heterogeneity, there is moderate evidence that a basal cortisol measured at 4–6 hours (and possibly 2–3 hours) post-trilostane dose can be a good test to rule out adrenal oversuppression, but that it cannot be used to definitively diagnose oversuppression. The current evidence suggests that basal cortisol is less useful for identification of inadequate control. Based on one included study, neither ACTH-stimulated nor basal cortisol levels correlate optimally with the actual clinical response of the patient. In this context, it can be concluded that none of the currently used laboratory tests should be used as a sole monitoring tool in dogs with hyperadrenocorticism receiving trilostane and thus, the assessment of the clinical response is of utmost importance   How to apply this evidence in practice The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources. Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on DOAJ: https://doi.org/10.18849/ve.v6i3.412